A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease

被引：0
作者：
Katherine W. Turk
Alexandra Geada
Victor E. Alvarez
Weiming Xia
Jonathan D. Cherry
Raymond Nicks
Gaoyuan Meng
Sarah Daley
Yorghos Tripodis
Bertrand R. Huber
Andrew E. Budson
Brigid Dwyer
Neil W. Kowall
Robert C. Cantu
Lee E. Goldstein
Douglas I. Katz
Robert A. Stern
Michael L. Alosco
Jesse Mez
Ann C. McKee
Thor D. Stein
机构：
[1] Boston University School of Medicine,Boston University Alzheimer’s Disease Research and CTE Center
[2] VA Boston Healthcare System,Department of Neurology
[3] Boston University School of Medicine,Department of Biostatistics
[4] Boston University School of Medicine,Department of Anatomy and Neurobiology
[5] VA Bedford Healthcare System,Department of Neurosurgery
[6] Boston University School of Public Health,Department of Neurosurgery
[7] Braintree Rehabilitation Hospital,Departments of Psychiatry, Ophthalmology
[8] Boston University School of Medicine,Departments of Biomedical, Electrical & Computer Engineering
[9] Concussion Legacy Foundation,Department of Pathology and Laboratory Medicine
[10] Boston University School of Medicine,undefined
[11] Emerson Hospital,undefined
[12] Boston University School of Medicine,undefined
[13] Boston University College of Engineering,undefined
[14] Boston University School of Medicine,undefined
来源：
Alzheimer's Research & Therapy | / 14卷
关键词：
Cerebrospinal fluid; Biomarkers; Chronic traumatic encephalopathy; Alzheimer’s disease; Amyloid beta; Tau;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 216 条
[1]  
McKee AC(2016)The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy Acta Neuropathol 131 75-86
[2]  
Cairns NJ(1992)Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer’s disease cases Acta Neuropathol 85 23-30
[3]  
Dickson DW(1991)Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid beta-protein and tau protein Acta Neuropathol 82 280-285
[4]  
Folkerth RD(1995)Staging of Alzheimer’s disease-related neurofibrillary changes Neurobiol Aging 16 271-278
[5]  
Keene CD(2019)Tau pathology in chronic traumatic encephalopathy and Alzheimer’s disease: similarities and differences Front Neurol 10 980-524
[6]  
Litvan I(2001)Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer’s disease Acta Neuropathol 101 518-34
[7]  
Hof PR(2021)Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics Mol Neurodegener 16 10-512
[8]  
Bouras C(2021)Cerebrospinal fluid biomarkers of Alzheimer’s disease: current evidence and future perspectives Brain Sci 11 215-1146
[9]  
Buee L(2020)Relevance of biomarkers across different neurodegenerative diseases Alzheimers Res Ther 12 56-768
[10]  
Delacourte A(2015)Beta-amyloid deposition in chronic traumatic encephalopathy Acta Neuropathol 130 21-64
12345678910